SequelSEC

Syra Health Corp SYRA

Services-Employment Agencies · CIK 0001922335 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$8.09M
Fiscal year ended 2026-06-30
Operating income
$74.72K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$979.54KMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.09Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.1×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.5×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

Syra Health Corp (SYRA) reported revenue of $8.09M and net income of $130.75K for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Syra Health Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Employment Agencies.

Income

Syra Health Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$8.09M
Cost of revenue$4.91M
Gross profit$3.18M
Operating income$74.72K
Net income$130.75K
Research & development$55.23K
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$938.55K
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Syra Health Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$2.12M
Total assets$3.83M
Current assets$3.75M
Total liabilities$1.20M
Current liabilities$1.20M
Total equity incl. NCI$2.63M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$1.47M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Syra Health Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$109.68K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow-$291.75K
Net change in cash-$182.18K
Stock-based compensation$88.93K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Syra Health Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin39.3%
Operating margin0.9%
FCF marginUnavailable
SBC / revenue1.1%
Current ratio3.13x
Revenue YoY growth0.3%
Net margin1.6%
R&D / revenue0.7%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SYRA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

JOB KFY

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.